(Q46407151)

21 December 2017

title

The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance (English)

1 reference

21 December 2017

1 reference

5

1 reference

21 December 2017

author name string

Pretorius MM

1

1 reference

21 December 2017

Gainer JV

2

1 reference

21 December 2017

Van Guilder GP

3

1 reference

21 December 2017

Coelho EB

4

1 reference

21 December 2017

Fong P

6

1 reference

21 December 2017

Rosenbaum DD

7

1 reference

21 December 2017

Malave HA

8

1 reference

21 December 2017

Yu C

9

1 reference

21 December 2017

Ritchie MD

10

1 reference

21 December 2017

Vaughan DE

11

1 reference

21 December 2017

Brown NJ

12

1 reference

21 December 2017

language of work or name

English

0 references

publication date

23 May 2007

1 reference

21 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

21 December 2017

volume

83

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

122-129

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100250

exact match

0 references

cites work

Endothelial dysfunction: from physiology to therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Does the Kinin System Mediate in Cardiovascular Abnormalities? An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

A novel sequence polymorphism in the promoter region of the human B2-bradykinin receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Sequence variation of bradykinin receptors B1 and B2 and association with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Bradykinin B2BKR receptor polymorphism and left-ventricular growth response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Bradykinin receptor gene variant and human physical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Ethnic differences in arterial responses and inflammatory markers in Afro-Caribbean and Caucasian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Salt sensitivity of blood pressure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Why is plasma renin activity lower in populations of African origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Race and gender differences in C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Ethnicity affects vasodilation, but not endothelial tissue plasminogen activator release, in response to bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Population Distribution of High-Sensitivity C-reactive Protein among US Men: Findings from National Health and Nutrition Examination Survey 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

Bradykinin stimulates tissue plasminogen activator release in human vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Genetic variation in the promoter region of the beta2 bradykinin receptor gene is associated with essential hypertension in a Chinese Han population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Racial differences in maximal vasodilatory capacity of forearm resistance vessels in normotensive young adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Interactive Effect of Ethnicity and ACE Insertion/Deletion Polymorphism on Vascular Reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100250

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100250

1 reference

21 December 2017

Dimensions Publication ID

0 references

1 reference

21 December 2017